System4 Technologies GmbH: Universal Therapy Device For COVID-19, COVID-19 Mutations, and Other Virus Variants Unveiled

System4 Technologies GmbH: Universal Therapy Device For COVID-19, COVID-19 Mutations, and Other Virus Variants Unveiled
Possible use in intensive care medicine and treatment of long COVID.
Planned large-scale study on universal use against coronaviruses and other RNA viruses.
BAD ZWISCHENAHN, GERMANY / ACCESSWIRE / April 21, 2021 / The life science company System4 Technologies GmbH has developed a new therapy device for the treatment of Covid patients.
The device, named PI-RNA, is designed to enable universal and fast deactivation of coronaviruses and influenza viruses, their mutations and new variants by means of
a special cold atmospheric plasma procedure. "The so-called CAP (Cold Atmospheric Plasma) - technology transfers electrostatically atmospheric anions, in high numbers and densities, into and around the body of the patient. This is achieved through a

Related Keywords

Hungary ,Tim Stelter ,Kostenloser Wertpapierhandel ,Benjamin Seibt ,Ilir Guslo ,Fraunhofer Institute For Toxicology ,Max Planck Institute ,Cold Atmospheric Plasma ,Managing Director ,Fraunhofer Institute ,System4 ,Technologies ,Mbh ,Niversal ,Therapy ,Device ,Covid ,Mutations ,Mother ,Virus ,Variants ,Nveiled ,பசி ,ப்ரௌுந்ொபேர் நிறுவனம் க்கு நச்சுயியல் ,குளிர் வளிமண்டலம் பிளாஸ்மா ,நிர்வகித்தல் இயக்குனர் ,ப்ரௌுந்ொபேர் நிறுவனம் ,ம்ப் ,விட் ,